vs
GENCO SHIPPING & TRADING LTD（GNK）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是GENCO SHIPPING & TRADING LTD的1.9倍（$207.3M vs $109.9M），GENCO SHIPPING & TRADING LTD净利率更高（14.0% vs -62.0%，领先76.0%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 10.8%），GENCO SHIPPING & TRADING LTD自由现金流更多（$15.6M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -3.3%）
GENCO航运贸易有限公司是一家国际干散货航运企业，运营多元化散货船船队，主要承运铁矿石、煤炭、粮食、钢材等大宗商品，航线覆盖全球主要贸易通道，服务工业制造、大宗商品交易领域的全球客户。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GNK vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $109.9M | $207.3M |
| 净利润 | $15.4M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 17.3% | -54.7% |
| 净利率 | 14.0% | -62.0% |
| 营收同比 | 10.8% | 25.9% |
| 净利润同比 | 21.6% | 3.5% |
| 每股收益（稀释后） | $0.36 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $109.9M | $207.3M | ||
| Q3 25 | $79.9M | $159.9M | ||
| Q2 25 | $80.9M | $166.5M | ||
| Q1 25 | $71.3M | $139.3M | ||
| Q4 24 | $99.2M | $164.6M | ||
| Q3 24 | $99.3M | $139.5M | ||
| Q2 24 | $107.0M | $147.0M | ||
| Q1 24 | $117.4M | $108.8M |
| Q4 25 | $15.4M | $-128.6M | ||
| Q3 25 | $-1.1M | $-180.4M | ||
| Q2 25 | $-6.8M | $-115.0M | ||
| Q1 25 | $-11.9M | $-151.1M | ||
| Q4 24 | $12.7M | $-133.2M | ||
| Q3 24 | $21.5M | $-133.5M | ||
| Q2 24 | $23.5M | $-131.6M | ||
| Q1 24 | $18.8M | $-170.7M |
| Q4 25 | 17.3% | -54.7% | ||
| Q3 25 | 3.1% | -106.9% | ||
| Q2 25 | -5.3% | -64.8% | ||
| Q1 25 | -13.7% | -102.6% | ||
| Q4 24 | 14.7% | -74.3% | ||
| Q3 24 | 24.2% | -94.6% | ||
| Q2 24 | 24.6% | -79.1% | ||
| Q1 24 | 18.8% | -151.9% |
| Q4 25 | 14.0% | -62.0% | ||
| Q3 25 | -1.3% | -112.8% | ||
| Q2 25 | -8.4% | -69.0% | ||
| Q1 25 | -16.7% | -108.5% | ||
| Q4 24 | 12.8% | -80.9% | ||
| Q3 24 | 21.6% | -95.7% | ||
| Q2 24 | 21.9% | -89.5% | ||
| Q1 24 | 16.0% | -156.8% |
| Q4 25 | $0.36 | $-1.28 | ||
| Q3 25 | $-0.02 | $-1.81 | ||
| Q2 25 | $-0.16 | $-1.17 | ||
| Q1 25 | $-0.28 | $-1.57 | ||
| Q4 24 | $0.29 | $-1.34 | ||
| Q3 24 | $0.49 | $-1.40 | ||
| Q2 24 | $0.54 | $-1.52 | ||
| Q1 24 | $0.43 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $55.5M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $896.5M | $-80.0M |
| 总资产 | $1.1B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $55.5M | $421.0M | ||
| Q3 25 | $90.0M | $202.5M | ||
| Q2 25 | $35.4M | $176.3M | ||
| Q1 25 | $30.2M | $127.1M | ||
| Q4 24 | $43.7M | $174.0M | ||
| Q3 24 | $46.7M | $150.6M | ||
| Q2 24 | $42.0M | $480.7M | ||
| Q1 24 | $48.4M | $112.3M |
| Q4 25 | $896.5M | $-80.0M | ||
| Q3 25 | $885.9M | $9.2M | ||
| Q2 25 | $891.6M | $151.3M | ||
| Q1 25 | $903.2M | $144.2M | ||
| Q4 24 | $926.7M | $255.0M | ||
| Q3 24 | $929.9M | $346.8M | ||
| Q2 24 | $921.8M | $432.4M | ||
| Q1 24 | $915.1M | $140.3M |
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $1.1B | $1.5B | ||
| Q3 24 | $1.0B | $1.5B | ||
| Q2 24 | $1.1B | $1.6B | ||
| Q1 24 | $1.1B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.9M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $15.6M | $-100.8M |
| 自由现金流率自由现金流/营收 | 14.2% | -48.6% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.03× | — |
| 过去12个月自由现金流最近4个季度 | $28.7M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $15.9M | $-99.8M | ||
| Q3 25 | $7.7M | $-91.4M | ||
| Q2 25 | $5.4M | $-108.3M | ||
| Q1 25 | $2.9M | $-166.5M | ||
| Q4 24 | $30.0M | $-79.3M | ||
| Q3 24 | $35.6M | $-67.0M | ||
| Q2 24 | $29.0M | $-77.0M | ||
| Q1 24 | $32.3M | $-190.7M |
| Q4 25 | $15.6M | $-100.8M | ||
| Q3 25 | $6.5M | $-92.7M | ||
| Q2 25 | $4.3M | $-110.7M | ||
| Q1 25 | $2.3M | $-167.8M | ||
| Q4 24 | $29.3M | $-79.5M | ||
| Q3 24 | $34.7M | $-68.6M | ||
| Q2 24 | $27.9M | $-79.0M | ||
| Q1 24 | $32.0M | $-193.9M |
| Q4 25 | 14.2% | -48.6% | ||
| Q3 25 | 8.2% | -58.0% | ||
| Q2 25 | 5.3% | -66.5% | ||
| Q1 25 | 3.2% | -120.5% | ||
| Q4 24 | 29.5% | -48.3% | ||
| Q3 24 | 34.9% | -49.2% | ||
| Q2 24 | 26.1% | -53.7% | ||
| Q1 24 | 27.3% | -178.2% |
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 1.5% | 0.8% | ||
| Q2 25 | 1.3% | 1.5% | ||
| Q1 25 | 0.9% | 1.0% | ||
| Q4 24 | 0.7% | 0.1% | ||
| Q3 24 | 0.9% | 1.2% | ||
| Q2 24 | 1.1% | 1.4% | ||
| Q1 24 | 0.2% | 3.0% |
| Q4 25 | 1.03× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.37× | — | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 1.24× | — | ||
| Q1 24 | 1.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GNK
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
